Operating Segments (Details)	3 Months Ended
	Mar. 31, 2024 USD ($) segment	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)
Segment reporting
Revenues	$ 117,029	$ 257,178
Income (loss) from Operations	(2,117,091)	(2,150,689)
Amortization and Depreciation Expense	1,588	1,785
Other (Expense) Income, Net	201,764	(56,617)
Share-Based Compensation	59,961	73,634
Identifiable Assets	$ 8,058,385		$ 9,797,326
Number of operating segments | segment	2
Operating Segments [Member] | Specialized BioTherapeutics [Member]
Segment reporting
Revenues	$ 117,029	155,365
Income (loss) from Operations	(860,604)	(910,377)
Amortization and Depreciation Expense	953	1,071
Other (Expense) Income, Net	7,540	6,082
Share-Based Compensation	20,672	27,427
Identifiable Assets	301,709		272,099
Operating Segments [Member] | Public Health Solutions [Member]
Segment reporting
Revenues		101,813
Income (loss) from Operations	(45,997)	427
Amortization and Depreciation Expense	159	178
Share-Based Compensation	588	994
Identifiable Assets	120,475		3,976
Corporate [Member]
Segment reporting
Income (loss) from Operations	(1,210,490)	(1,240,739)
Amortization and Depreciation Expense	476	536
Other (Expense) Income, Net	194,224	(62,699)
Share-Based Compensation	38,701	$ 45,213
Identifiable Assets	$ 7,636,201		$ 9,521,251